ISHITA  DRUGS & INDUSTRIES  LTD.Carp.  Off.:  401,  3rd   Eye   H,  Opp.  Parimal   Garden,  C.  G.  Road.  Ahmedabad-380006.
Regd.   Office    &    FaLctory    :    179/I,  Vasna-lyava,  Tal.   Sanand,   Disc.   :  Ahmedabad
E-mall  :iihadrugs@gmail,com  I   info@Ishltadrugs,com   I  URL : www.Ishludrug|cem
Phone :  +91 7226995613/14/ls  I    +9179  4002  3839
Date: 19.11.ZOZ5
TO,
Department of Corporate Services,
BSE Limited.
Floor No. Z5, Phiroze Jeejeebhoy Towers,
Da]a] Street, Mumbai-C400 0oi
ScriD Code: 524400
Dear Sir/Madam,
Sub: Disclosure under reoulation Z9rz` of SEBI rsLubstantial Acquisition of Shares and
Takeoversl Remilatious. 2011
With Reference to the captioned subject, please find enclosed the disclosure under regulation 29(2)
of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011:
a)           Acquisition of 125 shares of Rs.10/-each by lshita pharmaceuticals, related party of lshita
Drugs and Industries Ltd.
Please take the above disclosure on record.
Thanking You,
For, Ishita Drugs and Industries Limited
Abha Agrawal
Director
•Oiir base drigs tn thL. serince Of hiLmnrty u}or(d&Lrde.
CIN  No. L24231GJ1992PLC017054
D a a D-U-N-S Number -65-0180359

ESHHHyffi pffiffiREffi@yffiurE@7ffiusPhone: 91 -79 -26468353/7886, Email: harmal980 mail.com
Factory: 65/1, GIDC Industrial Estate, Wadhawan -363035, Surendranagar, India.
Date: 19.11.Z025
scrip code: 524400
TO,
Department of Corporate Services,
BSE Limited.
Floor No. 25, Phiroze je`9jeebhoy Towers,
Dalal Street, Mumbai-400 001
Ishita Drngs & Industries Ltd.
Office No: 401, 3rd Eye ||,
Opp. Parimal Garden, C.G. Road,
Ahmedabad - 380 006
Dear Sir/Madam,
Sub: Disc]o lation 29f2` of SEBI rsubstantial Acauisition Of shar
takeoversl Ren]lations. 2011
With Reference to the captioned subject, Ishita Pharmaceutlcals, related party of lshita Drugs and
Industries  Limited,  do  hereby inform you  that we have acquired  125  shares  of Rs.  10/-  each  of
lshita Drugs & Industries Ltd.
Please  find  enclosed  the  necessary  disclosure  as  required  under  regulation  29(2)  of the  SEBl
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Kindly, take the above information on your record.
Thankingyou,
Yours Faithfully,

EsffiITyffi pHrfeREffi©EuryE©yffiifePhone: 91 -79 -26468353/7886, Email: harmal980 mail.com
Factory: 65/1, GIDC Industrial Estate, Wadhawan -363035, Surendranagar, India.
Format for disdosures under Regulation 29(2) of SEBI (Substantial Acq_uisition of Shares
and Takeoversl ReEmlations, 2011
Name of the Target Company Crc) Ishita Drugs and Industries Limited
Name(s)   of  the  acquirer  and  Persons  Acting  in [shita Pharmaceuticals
Concert rpAcl with the acquirer
Whether         the          acquirer          bel ongs          to Related Patty of the Target Company
Promoter/ Promoter froup
Name(s)   of  the   Stock   Exchange(s)   where   the BSE Limited
shares ofTC are Listed
Details of the acquisition / disposal as follows Number % w.r.t. totalshare/votingcapitalwhereverapplicabler*1% w.r.t. totaldilutedshare/votingcapitaloftheTC('*)
Before the acquisition under consideration,
Z6160 0.88 0.88holding of :
a)    Shares carryingvotingrights
b)   Shares in the nature of encumbrance NilNil NilNil NilNil
(pledge/ lien/ non-disposal undertaking/
others)
c)   Voting rights (VR) otherwise than by
shares
d)   Warrants/convertible          securities/any Nil26160 Nil0.88 Nil0.88other     instrument     that     entitles     the
acquirer to receive shares carrying voting
rights in the T C  (specify holding in each
category)
e)    Total (a+b+c+d)

ISH`ITA PH`A.RMA`CEUTICALS
Phone: 91 -79 -26468353/7886, Email: harmal980 mail.com
Factory: 65/1, GIDC Industrial Estate, Wadhawan -363035, Surendranagar,  India.
Details of acquisition
125 0.00 0.00a)   Shares          carrying         voting          rights
acquired/seid
b)   VRs   acquired   /sold   otherwise   than   by Nil Nil Nilshares
c)   Warrants/convertible          securities/any NilNil NilNil NilNilother     instrument     that     entitles     the
acquirer to receive shares carrying voting
rights in the TC  (specify  holding in  each
category) acquired/sold
d)   Shares encumbered / invoked/released by
the acquirer 125 0.00 0.00e)    Total fa+b+c+d)
After the acquisition, holding of:
Z6285 0.88 0.88a)   Shares carrying voting rights
b)   Shares encumbered with the acquirer NIL NIL NIL
c)   VRs otherwise than byshares NIL NIIJ, NIL
d)   Warrants/convertible          securities/any NIL26285 NIL0.88 NIL0.88
other    instrument    that    entitles     the
acquirer to receive shares carrying voting
rights  in the TC  (specify holding in  each
category) after acquisition
e)    Total (a+b+c+d)
Mode of acquisition Open Market
Date of acquisition November 18, 2025
Equity share capital of the Target Company before Rs. 29903000/-(2990300 shares of Rs.10 each)
the said acquisition
Equity share  capital  of the  Target  Company after Rs. 29903000/-(2990300 shares of Rs.10 each)
the said acquisition
Total  diluted  share/voting  capital  of  the  Target Rs. 29903000/-(2990300 shares of Rs.10 each)
Company after the said acquisition
(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the
Stock Exchange under Clause 35 of the listing Agreement.
(**)   Diluted  share/voting  capital  means  the  total  number  of  shares  in  the  TC  assuming  full
conversion of the outstanding.Convertible securities/warrants into equity shares of the TC.
For lshita

